England announces roll-out of national lung cancer screening programme

England announces roll-out of national lung cancer screening programme

The Lung Cancer Policy Network warmly welcomes the news that a national targeted lung cancer screening programme is to be implemented across England.

Australia dedicates over $500 million to alleviating its lung cancer burden

The Lung Cancer Policy Network is pleased to learn of the Australian Government’s recent decision to dedicate more than AUD $500 million to reducing the burden of lung cancer.

Network hosts event in Copenhagen to demonstrate that collaboration is key in improving lung cancer survival

To coincide with ELCC 2023 the the Network hosted an event in Copenhagen to highlight the value of LDCT screening.

Behind the scenes of US Lung Cancer Screening Day

We speak with Tiffany Gowen, who shares her reflections on the inaugural National Lung Cancer Screening Day and her hopes for what 2023’s Screening Day could achieve.

New framework developed to support the implementation of low-dose CT lung cancer screening

The Lung Cancer Policy Network has published 'A framework to support implementation of LDCT lung cancer screening', to enable a robust assessment of readiness to implement a lung cancer screening programme.

UK National Screening Committee recommends introduction of targeted lung cancer screening

The Lung Cancer Policy Network is pleased to see the UK National Screening Committee’s recent announcement in favour of targeted lung cancer screening.

Now available: interactive map of lung cancer screening implementation

The Lung Cancer Policy Network is proud to announce the launch the interactive map of lung cancer screening implementation.

Register now for ‘Towards implementation: momentum for lung cancer screening in the EU’

Join the Lung Cancer Policy Network on 27 September for a virtual round table: turning recommendations into the implementation of lung cancer screening in the EU.

Out now — Lung cancer screening: learning from implementation

The report highlights the existing wealth of research in implementation of lung cancer screening and is supported by a variety of global case studies.

Meet our members: Professor Dorothy Keefe

We speak to Dorothy Keefe, CEO of Cancer Australia and honorary Clinical Professor in the School of Medicine at the University of Adelaide.

Meet our members: Professor Mariusz Adamek

Professor Adamek’s interests lie in lung cancer prevention and screening, as well as low-dose computed tomography with a particular focus on molecular biology methods, prediction models and image analysis.